Benedict Mark Q, Charlwood J Derek, Harrington Laura C, Lounibos L Philip, Reisen William K, Tabachnick Walter J
1 Entomology Branch, Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia .
2 Centre for Health Research and Development, Faculty of Life, University of Copenhagen , Copenhagen, Denmark .
Vector Borne Zoonotic Dis. 2018 Jan;18(1):39-48. doi: 10.1089/vbz.2017.2152.
Experimental releases of mosquitoes are performed to understand characteristics of populations related to the biology, ability to transmit pathogens, and ultimately their control. In this article, we discuss considerations related to the safety of experimental releases of living mosquitoes, applying principles of good practice in vector biology that protect human health and comfort. We describe specific factors of experimental releases of mosquitoes that we believe are critical to inform institutional biosafety committees and similar review boards to which proposals to conduct mosquito release experiments have been submitted. In this study, "experimental releases" means those that do not significantly increase vector capacity or nuisance biting relative to the unperturbed natural baseline. This document specifically does not address releases of mosquitoes for ongoing control programs or trials of new control methods for which broader assessments of risk are required. It also does not address releases of transgenic or exotic (non-native) mosquito species, both of which require particular regulatory approval. Experimental releases may include females and males and evaluation must consider their effects based on the number released, their genotype and phenotype, the environment into which they are released, and postrelease collection activities. We consider whether increases of disease transmission and nuisance biting might result from proposed experimental releases against the backdrop of natural population size variation. We recommend that experimental releases be conducted in a manner that can be reasonably argued to have insignificant negative effects. Reviewers of proposals for experimental releases should expect applicants to provide such an argument based on evidence from similar studies and their planned activities. This document provides guidance for creating and evaluating such proposals.
进行蚊子的实验性释放是为了了解与生物学、传播病原体能力以及最终控制相关的种群特征。在本文中,我们讨论与活蚊子实验性释放安全性相关的考虑因素,应用媒介生物学的良好实践原则来保护人类健康和舒适度。我们描述了蚊子实验性释放的具体因素,我们认为这些因素对于告知机构生物安全委员会和类似的审查委员会至关重要,向这些委员会提交了进行蚊子释放实验的提案。在本研究中,“实验性释放”是指相对于未受干扰的自然基线而言,不会显著增加媒介能力或滋扰性叮咬的释放。本文件具体不涉及正在进行的控制项目中蚊子的释放或需要进行更广泛风险评估的新控制方法的试验。它也不涉及转基因或外来(非本地)蚊子物种的释放,这两者都需要特定的监管批准。实验性释放可能包括雌性和雄性蚊子,评估必须根据释放的数量、它们的基因型和表型、释放的环境以及释放后的收集活动来考虑它们的影响。我们考虑在自然种群数量变化的背景下,拟议的实验性释放是否可能导致疾病传播和滋扰性叮咬的增加。我们建议以一种可以合理论证其负面影响微不足道的方式进行实验性释放。实验性释放提案的评审人员应期望申请人根据类似研究的证据和他们计划的活动提供这样的论证。本文件为创建和评估此类提案提供指导。